Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Document › Details

Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN.

	Organisation	Beckman Coulter Inc., Life Science Division (Beckman Coulter Life Sciences)
	Today	Beckman Coulter Life Sciences
	Group	Danaher (Group)
	Organisation 2	Labcyte Inc.
	Group	Danaher (Group)
	Product	acoustic droplet ejection technology (ADE technology)
	Index term	Labcyte–Danaher: investment, 201901 acquisition of Labcyte by Beckman Coulter Life Sciences
	Person	Pratt, Jonathan M. (Jon) (Waters 201909– President of TA Instruments before Beckman Coulter Life Sciences + Pall Corp)
	Person 2	Ellson, Richard (Labcyte 200703 CTO)

Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.

Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with unequalled speed and accuracy. This technology—the centerpiece of Labcyte’s Echo Liquid Handlers—enables walkaway convenience and integration capabilities. Labcyte technology enables faster and more cost-effective laboratory workflows in applications such as drug discovery and genomics.

“Labcyte’s unique product portfolio complements our existing liquid handling and laboratory automation business. It provides new opportunities to develop and enhance time-saving solutions for customer workflows,” said Jonathan Pratt, President, Beckman Coulter Life Sciences. “Labcyte and Beckman Coulter Life Sciences share a common vision of advancing science through discovery, enabling the faster discovery and development of life-changing advances in medicine. Together we will make a powerful team, and an invaluable resource for current and future customers around the world.”

“It has been an exciting journey—from developing acoustic liquid-dispensing technology in a garage to establishing a global presence, and now to be joining forces with a life sciences technology leader,” said Richard Ellson, CTO and a Founder of Labcyte. “Acoustic liquid handling is quickly becoming the backbone for high-throughput, automated workflows, and we look forward to accelerating growth and innovation as part of the Beckman Coulter Life Sciences team.”

Labcyte will transition into Beckman Coulter Life Sciences under the larger Danaher Life Sciences platform of companies, which generates approximately $6.5 billion in annual revenue.

About Labcyte, Inc.

Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 63 U.S. patents and others internationally.

Record changed: 2023-06-05